|
US8124759B2
(en)
*
|
2007-05-09 |
2012-02-28 |
Abbott Laboratories |
Inhibitors of protein kinases
|
|
US8242085B2
(en)
|
2007-05-10 |
2012-08-14 |
Biocryst Pharmaceuticals, Inc. |
Tetrahydrofuro [3,4-D] dioxolane compounds for use in the treatment of viral infections and cancer
|
|
TW200942243A
(en)
*
|
2008-03-05 |
2009-10-16 |
Biocryst Pharm Inc |
Antiviral therapeutic agents
|
|
US20090247750A1
(en)
*
|
2008-03-28 |
2009-10-01 |
Biocryst Pharmaceuticals, Inc. |
Process for preparing nucleoside analogs
|
|
EA020659B1
(ru)
|
2008-04-23 |
2014-12-30 |
Джилид Сайэнс, Инк. |
1'-замещённые карбануклеозидные аналоги для противовирусной терапии
|
|
WO2010002877A2
(en)
|
2008-07-03 |
2010-01-07 |
Biota Scientific Management |
Bycyclic nucleosides and nucleotides as therapeutic agents
|
|
JP5746638B2
(ja)
|
2009-02-10 |
2015-07-08 |
ギリアード サイエンシーズ， インコーポレイテッド |
抗ウイルス処置のためのカルバ−ヌクレオシドアナログ
|
|
US8455451B2
(en)
|
2009-09-21 |
2013-06-04 |
Gilead Sciences, Inc. |
2'-fluoro substituted carba-nucleoside analogs for antiviral treatment
|
|
CN102596979B
(zh)
|
2009-09-21 |
2014-12-10 |
吉里德科学公司 |
用于制备1’-取代碳核苷类似物的方法和中间体
|
|
US7973013B2
(en)
|
2009-09-21 |
2011-07-05 |
Gilead Sciences, Inc. |
2'-fluoro substituted carba-nucleoside analogs for antiviral treatment
|
|
CA2773772C
(en)
*
|
2009-09-21 |
2018-06-26 |
Gilead Sciences, Inc. |
2'-fluoro substituted carba-nucleoside analogs for antiviral treatment
|
|
US8791257B2
(en)
|
2010-03-31 |
2014-07-29 |
Bristol-Myers Squibb Company |
Substituted pyrrolotriazines as protein kinase inhibitors
|
|
TW201201815A
(en)
|
2010-05-28 |
2012-01-16 |
Gilead Sciences Inc |
1'-substituted-carba-nucleoside prodrugs for antiviral treatment
|
|
ES2524398T3
(es)
|
2010-07-19 |
2014-12-09 |
Gilead Sciences, Inc. |
Métodos para la preparación de profármacos de fosforoamidato diastereoméricamente puros
|
|
EA025252B1
(ru)
|
2010-07-22 |
2016-12-30 |
Гайлид Сайэнсиз, Инк. |
Способы и соединения для лечения вирусных инфекций paramyxoviridae
|
|
TW201305185A
(zh)
*
|
2010-09-13 |
2013-02-01 |
Gilead Sciences Inc |
用於抗病毒治療之２’－氟取代之碳－核苷類似物
|
|
AP3699A
(en)
|
2010-09-20 |
2016-05-31 |
Gilead Sciences Inc |
2'-fluoro substituted carba-nucleoside analogs for antiviral treatment
|
|
CA2812962C
(en)
|
2010-09-22 |
2020-03-31 |
Alios Biopharma, Inc. |
Azido nucleosides and nucleotide analogs
|
|
US8754114B2
(en)
|
2010-12-22 |
2014-06-17 |
Incyte Corporation |
Substituted imidazopyridazines and benzimidazoles as inhibitors of FGFR3
|
|
WO2012142523A2
(en)
|
2011-04-13 |
2012-10-18 |
Gilead Sciences, Inc. |
1'-substituted pyrimidine n-nucleoside analogs for antiviral treatment
|
|
SG195100A1
(en)
|
2011-07-01 |
2013-12-30 |
Bayer Ip Gmbh |
Hydroxymethylaryl-substituted pyrrolotriazines as alk1 inhibitors
|
|
AR088441A1
(es)
|
2011-09-12 |
2014-06-11 |
Idenix Pharmaceuticals Inc |
Compuestos de carboniloximetilfosforamidato sustituido y composiciones farmaceuticas para el tratamiento de infecciones virales
|
|
CA2752008A1
(en)
|
2011-09-13 |
2013-03-13 |
Universite De Montreal |
Combination therapy using ribavirin as elf4e inhibitor
|
|
AU2012358803C1
(en)
|
2011-12-22 |
2019-12-19 |
Janssen Biopharma, Inc. |
Substituted nucleosides, nucleotides and analogs thereof
|
|
CN106749272B
(zh)
|
2012-03-13 |
2019-08-30 |
吉利德科学公司 |
用于抗病毒治疗的2’-取代的卡巴-核苷类似物
|
|
US9441007B2
(en)
|
2012-03-21 |
2016-09-13 |
Alios Biopharma, Inc. |
Substituted nucleosides, nucleotides and analogs thereof
|
|
USRE48171E1
(en)
|
2012-03-21 |
2020-08-25 |
Janssen Biopharma, Inc. |
Substituted nucleosides, nucleotides and analogs thereof
|
|
AR090699A1
(es)
|
2012-04-18 |
2014-12-03 |
Biocryst Pharm Inc |
Compuestos inhibidores de la actividad de la arn polimerasa viral
|
|
CN107652289B
(zh)
|
2012-06-13 |
2020-07-21 |
因塞特控股公司 |
作为fgfr抑制剂的取代的三环化合物
|
|
US9388185B2
(en)
|
2012-08-10 |
2016-07-12 |
Incyte Holdings Corporation |
Substituted pyrrolo[2,3-b]pyrazines as FGFR inhibitors
|
|
CA2890905A1
(en)
*
|
2012-11-16 |
2014-05-22 |
Biocryst Pharmaceuticals, Inc. |
Antiviral azasugar-containing nucleosides
|
|
US9266892B2
(en)
|
2012-12-19 |
2016-02-23 |
Incyte Holdings Corporation |
Fused pyrazoles as FGFR inhibitors
|
|
JP6449244B2
(ja)
|
2013-04-19 |
2019-01-09 |
インサイト・ホールディングス・コーポレイションＩｎｃｙｔｅ Ｈｏｌｄｉｎｇｓ Ｃｏｒｐｏｒａｔｉｏｎ |
Ｆｇｆｒ抑制剤としての二環式複素環
|
|
US9862743B2
(en)
|
2013-10-11 |
2018-01-09 |
Alios Biopharma, Inc. |
Substituted nucleosides, nucleotides and analogs thereof
|
|
UA119050C2
(uk)
|
2013-11-11 |
2019-04-25 |
Ґілеад Саєнсиз, Інк. |
ПІРОЛО[1.2-f][1.2.4]ТРИАЗИНИ, ЯКІ ВИКОРИСТОВУЮТЬСЯ ДЛЯ ЛІКУВАННЯ РЕСПІРАТОРНО-СИНЦИТІАЛЬНИХ ВІРУСНИХ ІНФЕКЦІЙ
|
|
WO2015143712A1
(en)
|
2014-03-28 |
2015-10-01 |
Merck Sharp & Dohme Corp. |
4'-substituted nucleoside reverse transcriptase inhibitors
|
|
TWI678369B
(zh)
|
2014-07-28 |
2019-12-01 |
美商基利科學股份有限公司 |
用於治療呼吸道合胞病毒感染之噻吩並［３,２-ｄ］嘧啶、呋喃並［３,２-ｄ］嘧啶及吡咯並［３,２-ｄ］嘧啶化合物類
|
|
TWI673283B
(zh)
|
2014-08-21 |
2019-10-01 |
美商基利科學股份有限公司 |
２’－氯胺基嘧啶酮及嘧啶二酮核苷類
|
|
US10214537B2
(en)
|
2014-10-22 |
2019-02-26 |
Bristol-Myers Squibb Company |
Bicyclic heteroaryl amine compounds
|
|
WO2016064958A1
(en)
|
2014-10-22 |
2016-04-28 |
Bristol-Myers Squibb Company |
Heteroaryl substituted pyrrolotriazine amine compounds as pi3k inhibitors
|
|
US10851105B2
(en)
|
2014-10-22 |
2020-12-01 |
Incyte Corporation |
Bicyclic heterocycles as FGFR4 inhibitors
|
|
TWI698444B
(zh)
*
|
2014-10-29 |
2020-07-11 |
美商基利科學股份有限公司 |
製備核糖苷的方法
|
|
WO2016134294A1
(en)
|
2015-02-20 |
2016-08-25 |
Incyte Corporation |
Bicyclic heterocycles as fgfr4 inhibitors
|
|
ES2751669T3
(es)
|
2015-02-20 |
2020-04-01 |
Incyte Corp |
Heterociclos bicíclicos como inhibidores FGFR
|
|
MA41551A
(fr)
|
2015-02-20 |
2017-12-26 |
Incyte Corp |
Hétérocycles bicycliques utilisés en tant qu'inhibiteurs de fgfr4
|
|
GEP20237502B
(en)
|
2015-03-06 |
2023-04-25 |
Atea Pharmaceuticals Inc |
B-D-2'-DEOXY-2'a-FLUORO-2'-B-C-SUBSTITUTED-2-MODIFIED-N6-SUBSTITUTED PURINE NUCLEOTIDES FOR HCV TREATMENT
|
|
CN104876935B
(zh)
*
|
2015-05-18 |
2017-04-19 |
南方医科大学 |
2‑氨基吡咯并[1,2‑f][1,2,4]三嗪类化合物、合成方法及应用
|
|
MA52371A
(fr)
|
2015-09-16 |
2021-09-22 |
Gilead Sciences Inc |
Méthodes de traitement d'infections dues aux coronaviridae
|
|
AU2016328303B2
(en)
|
2015-09-23 |
2019-05-02 |
Merck Sharp & Dohme (Uk) Limited |
4'-substituted nucleoside reverse transcriptase inhibitors and preparations thereof
|
|
WO2017155949A1
(en)
|
2016-03-09 |
2017-09-14 |
Los Angeles Biomedical Research Institute At Harbor-Ucla Medical Center |
Methods and kits for use in preventing and treating vulvovaginal candidiasis
|
|
TWI740910B
(zh)
|
2016-03-09 |
2021-10-01 |
美商艾洛斯生物製藥公司 |
非環抗病毒劑
|
|
HUE064656T2
(hu)
|
2016-03-28 |
2024-04-28 |
Incyte Corp |
Pirrolotriazin vegyületek mint TAM inhibitorok
|
|
US10711029B2
(en)
|
2016-07-14 |
2020-07-14 |
Atea Pharmaceuticals, Inc. |
Beta-d-2′-deoxy-2′-alpha-fluoro-2′-beta-c-substituted-4′fluoro-n6-substituted-6-amino-2-substituted purine nucleotides for the treatment of hepatitis c virus infection
|
|
EA202190602A3
(ru)
|
2016-09-07 |
2021-11-30 |
Атеа Фармасьютикалс, Инк. |
2'-замещенные-n6-замещенные пуриновые нуклеотиды для лечения вызванных рнк-вирусом заболеваний
|
|
EP3538108A4
(en)
*
|
2016-11-10 |
2020-06-17 |
Oyagen, Inc. |
METHODS OF TREATING AND INHIBITING EBOLA VIRUS INFECTION
|
|
GEP20237457B
(en)
|
2017-02-01 |
2023-01-10 |
Atea Pharmaceuticals Inc |
Nucleotide hemi-sulfate salt for treatment of hepatitis c virus
|
|
CN110869028B
(zh)
|
2017-03-14 |
2023-01-20 |
吉利德科学公司 |
治疗猫冠状病毒感染的方法
|
|
CN115403626A
(zh)
|
2017-05-01 |
2022-11-29 |
吉利德科学公司 |
新结晶形式
|
|
CN107056775A
(zh)
*
|
2017-05-24 |
2017-08-18 |
佛山科学技术学院 |
丙型肝炎病毒ns5b聚合酶抑制剂
|
|
AR111960A1
(es)
|
2017-05-26 |
2019-09-04 |
Incyte Corp |
Formas cristalinas de un inhibidor de fgfr y procesos para su preparación
|
|
CA3077489A1
(en)
|
2017-07-11 |
2019-01-17 |
Gilead Sciences, Inc. |
Compositions comprising an rna polymerase inhibitor and cyclodextrin for treating viral infections
|
|
US11040975B2
(en)
|
2017-12-08 |
2021-06-22 |
Merck Sharp & Dohme Corp. |
Carbocyclic nucleoside reverse transcriptase inhibitors
|
|
JP2021521118A
(ja)
|
2018-04-10 |
2021-08-26 |
アテア ファーマシューティカルズ， インコーポレイテッド |
肝硬変を伴うｈｃｖ感染患者の治療
|
|
CN119241541A
(zh)
|
2018-05-04 |
2025-01-03 |
因赛特公司 |
Fgfr抑制剂的固体形式和其制备方法
|
|
PE20210919A1
(es)
|
2018-05-04 |
2021-05-19 |
Incyte Corp |
Sales de un inhibidor de fgfr
|
|
MX2021006993A
(es)
|
2018-12-12 |
2021-10-22 |
Janssen Biopharma Inc |
Analogos de nucleosidos de ciclopentilo como antivirales.
|
|
WO2020185532A1
(en)
|
2019-03-08 |
2020-09-17 |
Incyte Corporation |
Methods of treating cancer with an fgfr inhibitor
|
|
US11591329B2
(en)
|
2019-07-09 |
2023-02-28 |
Incyte Corporation |
Bicyclic heterocycles as FGFR inhibitors
|
|
WO2021067374A1
(en)
|
2019-10-01 |
2021-04-08 |
Incyte Corporation |
Bicyclic heterocycles as fgfr inhibitors
|
|
GEP20247679B
(en)
|
2019-10-14 |
2024-10-10 |
Incyte Corp |
Bicyclic heterocycles as fgfr inhibitors
|
|
US11566028B2
(en)
|
2019-10-16 |
2023-01-31 |
Incyte Corporation |
Bicyclic heterocycles as FGFR inhibitors
|
|
CA3163875A1
(en)
|
2019-12-04 |
2021-06-10 |
Incyte Corporation |
Tricyclic heterocycles as fgfr inhibitors
|
|
IL293001A
(en)
|
2019-12-04 |
2022-07-01 |
Incyte Corp |
Derivatives of fgfr repressors
|
|
US12012409B2
(en)
|
2020-01-15 |
2024-06-18 |
Incyte Corporation |
Bicyclic heterocycles as FGFR inhibitors
|
|
CA3163424A1
(en)
|
2020-01-27 |
2021-08-05 |
Gilead Sciences, Inc. |
Methods for treating sars cov-2 infections
|
|
WO2021158248A1
(en)
|
2020-02-04 |
2021-08-12 |
Oyagen, Inc. |
Method for treating coronavirus infections
|
|
CN113214262B
(zh)
*
|
2020-02-05 |
2023-07-07 |
华创合成制药股份有限公司 |
一种含有胍基的化合物及其制备方法和用途
|
|
TWI775313B
(zh)
|
2020-02-18 |
2022-08-21 |
美商基利科學股份有限公司 |
抗病毒化合物
|
|
JP7429799B2
(ja)
|
2020-02-18 |
2024-02-08 |
ギリアード サイエンシーズ， インコーポレイテッド |
抗ウイルス化合物
|
|
TWI794742B
(zh)
|
2020-02-18 |
2023-03-01 |
美商基利科學股份有限公司 |
抗病毒化合物
|
|
TWI884403B
(zh)
|
2020-02-18 |
2025-05-21 |
美商基利科學股份有限公司 |
抗病毒化合物
|
|
US10874687B1
(en)
|
2020-02-27 |
2020-12-29 |
Atea Pharmaceuticals, Inc. |
Highly active compounds against COVID-19
|
|
TWI890963B
(zh)
|
2020-03-12 |
2025-07-21 |
美商基利科學股份有限公司 |
1'-氰基核苷之製備方法
|
|
CA3172483A1
(en)
|
2020-04-06 |
2021-10-14 |
Scott Ellis |
Inhalation formulations of 1'-cyano substituted carbanucleoside analogs
|
|
CA3179226A1
(en)
|
2020-05-29 |
2021-12-02 |
Tomas Cihlar |
Remdesivir treatment methods
|
|
KR102911165B1
(ko)
|
2020-06-24 |
2026-01-13 |
길리애드 사이언시즈, 인코포레이티드 |
1'-시아노 뉴클레오시드 유사체 및 이의 용도
|
|
CN114190092B
(zh)
*
|
2020-07-14 |
2023-07-18 |
四川大学 |
3-去氧-2-酮糖酸含氮衍生物及其制备方法和用途
|
|
SI4204421T1
(sl)
|
2020-08-27 |
2024-07-31 |
Gilead Sciences, Inc., |
Spojine in postopki za zdravljenje virusnih okužb
|
|
JP2024513575A
(ja)
|
2021-04-12 |
2024-03-26 |
インサイト・コーポレイション |
Ｆｇｆｒ阻害剤及びネクチン－４標的化剤を含む併用療法
|
|
US11697666B2
(en)
|
2021-04-16 |
2023-07-11 |
Gilead Sciences, Inc. |
Methods of preparing carbanucleosides using amides
|
|
WO2022261160A1
(en)
|
2021-06-09 |
2022-12-15 |
Incyte Corporation |
Tricyclic heterocycles as fgfr inhibitors
|
|
AR126101A1
(es)
|
2021-06-09 |
2023-09-13 |
Incyte Corp |
Heterociclos tricíclicos como inhibidores de fgfr
|
|
KR20240022574A
(ko)
|
2021-06-17 |
2024-02-20 |
아테아 파마슈티컬즈, 인크. |
유리한 항-hcv 조합 요법
|
|
KR20240049311A
(ko)
|
2021-08-18 |
2024-04-16 |
길리애드 사이언시즈, 인코포레이티드 |
인지질 화합물 및 이의 제조 및 사용 방법
|
|
KR20240050362A
(ko)
|
2021-08-20 |
2024-04-18 |
시오노기 앤드 컴파니, 리미티드 |
바이러스 증식 억제 작용을 갖는 뉴클레오사이드 유도체 및 그들의 프로드러그
|
|
IL315102A
(en)
|
2022-03-02 |
2024-10-01 |
Gilead Sciences Inc |
COMPOSITIONS AND METHODS FOR THE TREATMENT OF VIRAL INFECTIONS
|
|
US12357577B1
(en)
|
2024-02-02 |
2025-07-15 |
Gilead Sciences, Inc. |
Pharmaceutical formulations and uses thereof
|